Global Split Influenza Vaccine Supply, Demand and Key Producers, 2023-2029

Page: 99

Published Date: 28 Apr 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Split Influenza Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Influenza virus split vaccine is made by inoculating chicken embryos with influenza virus strains recommended by the World Health Organization (WHO) and approved by the national drug administration department, cultured, harvested virus liquid, virus inactivated, purified, and cracked. For the prevention of influenza caused by this type of virus.

This report studies the global Split Influenza Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Split Influenza Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Split Influenza Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Split Influenza Vaccine total production and demand, 2018-2029, (K Units)
Global Split Influenza Vaccine total production value, 2018-2029, (USD Million)
Global Split Influenza Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Split Influenza Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Split Influenza Vaccine domestic production, consumption, key domestic manufacturers and share
Global Split Influenza Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Split Influenza Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Split Influenza Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Split Influenza Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, CSL Seqirus, GSK, Seqirus, Inc., straZeneca and Dalian Yali Peak, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Split Influenza Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Split Influenza Vaccine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Split Influenza Vaccine Market, Segmentation by Type
    Aldult
    Child

Global Split Influenza Vaccine Market, Segmentation by Application
    Hospital
    Clinic

Companies Profiled:
    Sanofi Pasteur
    CSL Seqirus
    GSK
    Seqirus, Inc.
    straZeneca
    Dalian Yali Peak

Key Questions Answered
1. How big is the global Split Influenza Vaccine market?
2. What is the demand of the global Split Influenza Vaccine market?
3. What is the year over year growth of the global Split Influenza Vaccine market?
4. What is the production and production value of the global Split Influenza Vaccine market?
5. Who are the key producers in the global Split Influenza Vaccine market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Split Influenza Vaccine Introduction
    1.2 World Split Influenza Vaccine Supply & Forecast
        1.2.1 World Split Influenza Vaccine Production Value (2018 & 2022 & 2029)
        1.2.2 World Split Influenza Vaccine Production (2018-2029)
        1.2.3 World Split Influenza Vaccine Pricing Trends (2018-2029)
    1.3 World Split Influenza Vaccine Production by Region (Based on Production Site)
        1.3.1 World Split Influenza Vaccine Production Value by Region (2018-2029)
        1.3.2 World Split Influenza Vaccine Production by Region (2018-2029)
        1.3.3 World Split Influenza Vaccine Average Price by Region (2018-2029)
        1.3.4 North America Split Influenza Vaccine Production (2018-2029)
        1.3.5 Europe Split Influenza Vaccine Production (2018-2029)
        1.3.6 China Split Influenza Vaccine Production (2018-2029)
        1.3.7 Japan Split Influenza Vaccine Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Split Influenza Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Split Influenza Vaccine Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Split Influenza Vaccine Demand (2018-2029)
    2.2 World Split Influenza Vaccine Consumption by Region
        2.2.1 World Split Influenza Vaccine Consumption by Region (2018-2023)
        2.2.2 World Split Influenza Vaccine Consumption Forecast by Region (2024-2029)
    2.3 United States Split Influenza Vaccine Consumption (2018-2029)
    2.4 China Split Influenza Vaccine Consumption (2018-2029)
    2.5 Europe Split Influenza Vaccine Consumption (2018-2029)
    2.6 Japan Split Influenza Vaccine Consumption (2018-2029)
    2.7 South Korea Split Influenza Vaccine Consumption (2018-2029)
    2.8 ASEAN Split Influenza Vaccine Consumption (2018-2029)
    2.9 India Split Influenza Vaccine Consumption (2018-2029)

3 World Split Influenza Vaccine Manufacturers Competitive Analysis
    3.1 World Split Influenza Vaccine Production Value by Manufacturer (2018-2023)
    3.2 World Split Influenza Vaccine Production by Manufacturer (2018-2023)
    3.3 World Split Influenza Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Split Influenza Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Split Influenza Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Split Influenza Vaccine in 2022
        3.5.3 Global Concentration Ratios (CR8) for Split Influenza Vaccine in 2022
    3.6 Split Influenza Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Split Influenza Vaccine Market: Region Footprint
        3.6.2 Split Influenza Vaccine Market: Company Product Type Footprint
        3.6.3 Split Influenza Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Split Influenza Vaccine Production Value Comparison
        4.1.1 United States VS China: Split Influenza Vaccine Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Split Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Split Influenza Vaccine Production Comparison
        4.2.1 United States VS China: Split Influenza Vaccine Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Split Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Split Influenza Vaccine Consumption Comparison
        4.3.1 United States VS China: Split Influenza Vaccine Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Split Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Split Influenza Vaccine Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Split Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Split Influenza Vaccine Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Split Influenza Vaccine Production (2018-2023)
    4.5 China Based Split Influenza Vaccine Manufacturers and Market Share
        4.5.1 China Based Split Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Split Influenza Vaccine Production Value (2018-2023)
        4.5.3 China Based Manufacturers Split Influenza Vaccine Production (2018-2023)
    4.6 Rest of World Based Split Influenza Vaccine Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Split Influenza Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Split Influenza Vaccine Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Split Influenza Vaccine Production (2018-2023)

5 Market Analysis by Type
    5.1 World Split Influenza Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Aldult
        5.2.2 Child
    5.3 Market Segment by Type
        5.3.1 World Split Influenza Vaccine Production by Type (2018-2029)
        5.3.2 World Split Influenza Vaccine Production Value by Type (2018-2029)
        5.3.3 World Split Influenza Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Split Influenza Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
    6.3 Market Segment by Application
        6.3.1 World Split Influenza Vaccine Production by Application (2018-2029)
        6.3.2 World Split Influenza Vaccine Production Value by Application (2018-2029)
        6.3.3 World Split Influenza Vaccine Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Sanofi Pasteur
        7.1.1 Sanofi Pasteur Details
        7.1.2 Sanofi Pasteur Major Business
        7.1.3 Sanofi Pasteur Split Influenza Vaccine Product and Services
        7.1.4 Sanofi Pasteur Split Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Sanofi Pasteur Recent Developments/Updates
        7.1.6 Sanofi Pasteur Competitive Strengths & Weaknesses
    7.2 CSL Seqirus
        7.2.1 CSL Seqirus Details
        7.2.2 CSL Seqirus Major Business
        7.2.3 CSL Seqirus Split Influenza Vaccine Product and Services
        7.2.4 CSL Seqirus Split Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 CSL Seqirus Recent Developments/Updates
        7.2.6 CSL Seqirus Competitive Strengths & Weaknesses
    7.3 GSK
        7.3.1 GSK Details
        7.3.2 GSK Major Business
        7.3.3 GSK Split Influenza Vaccine Product and Services
        7.3.4 GSK Split Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 GSK Recent Developments/Updates
        7.3.6 GSK Competitive Strengths & Weaknesses
    7.4 Seqirus, Inc.
        7.4.1 Seqirus, Inc. Details
        7.4.2 Seqirus, Inc. Major Business
        7.4.3 Seqirus, Inc. Split Influenza Vaccine Product and Services
        7.4.4 Seqirus, Inc. Split Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Seqirus, Inc. Recent Developments/Updates
        7.4.6 Seqirus, Inc. Competitive Strengths & Weaknesses
    7.5 straZeneca
        7.5.1 straZeneca Details
        7.5.2 straZeneca Major Business
        7.5.3 straZeneca Split Influenza Vaccine Product and Services
        7.5.4 straZeneca Split Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 straZeneca Recent Developments/Updates
        7.5.6 straZeneca Competitive Strengths & Weaknesses
    7.6 Dalian Yali Peak
        7.6.1 Dalian Yali Peak Details
        7.6.2 Dalian Yali Peak Major Business
        7.6.3 Dalian Yali Peak Split Influenza Vaccine Product and Services
        7.6.4 Dalian Yali Peak Split Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Dalian Yali Peak Recent Developments/Updates
        7.6.6 Dalian Yali Peak Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Split Influenza Vaccine Industry Chain
    8.2 Split Influenza Vaccine Upstream Analysis
        8.2.1 Split Influenza Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Split Influenza Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Split Influenza Vaccine Production Mode
    8.6 Split Influenza Vaccine Procurement Model
    8.7 Split Influenza Vaccine Industry Sales Model and Sales Channels
        8.7.1 Split Influenza Vaccine Sales Model
        8.7.2 Split Influenza Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Split Influenza Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Split Influenza Vaccine Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Split Influenza Vaccine Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Split Influenza Vaccine Production Value Market Share by Region (2018-2023)
    Table 5. World Split Influenza Vaccine Production Value Market Share by Region (2024-2029)
    Table 6. World Split Influenza Vaccine Production by Region (2018-2023) & (K Units)
    Table 7. World Split Influenza Vaccine Production by Region (2024-2029) & (K Units)
    Table 8. World Split Influenza Vaccine Production Market Share by Region (2018-2023)
    Table 9. World Split Influenza Vaccine Production Market Share by Region (2024-2029)
    Table 10. World Split Influenza Vaccine Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Split Influenza Vaccine Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Split Influenza Vaccine Major Market Trends
    Table 13. World Split Influenza Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Split Influenza Vaccine Consumption by Region (2018-2023) & (K Units)
    Table 15. World Split Influenza Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Split Influenza Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Split Influenza Vaccine Producers in 2022
    Table 18. World Split Influenza Vaccine Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Split Influenza Vaccine Producers in 2022
    Table 20. World Split Influenza Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Split Influenza Vaccine Company Evaluation Quadrant
    Table 22. World Split Influenza Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Split Influenza Vaccine Production Site of Key Manufacturer
    Table 24. Split Influenza Vaccine Market: Company Product Type Footprint
    Table 25. Split Influenza Vaccine Market: Company Product Application Footprint
    Table 26. Split Influenza Vaccine Competitive Factors
    Table 27. Split Influenza Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Split Influenza Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Split Influenza Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Split Influenza Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Split Influenza Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Split Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Split Influenza Vaccine Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Split Influenza Vaccine Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Split Influenza Vaccine Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Split Influenza Vaccine Production Market Share (2018-2023)
    Table 37. China Based Split Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Split Influenza Vaccine Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Split Influenza Vaccine Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Split Influenza Vaccine Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Split Influenza Vaccine Production Market Share (2018-2023)
    Table 42. Rest of World Based Split Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Split Influenza Vaccine Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Split Influenza Vaccine Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Split Influenza Vaccine Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Split Influenza Vaccine Production Market Share (2018-2023)
    Table 47. World Split Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Split Influenza Vaccine Production by Type (2018-2023) & (K Units)
    Table 49. World Split Influenza Vaccine Production by Type (2024-2029) & (K Units)
    Table 50. World Split Influenza Vaccine Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Split Influenza Vaccine Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Split Influenza Vaccine Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Split Influenza Vaccine Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Split Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Split Influenza Vaccine Production by Application (2018-2023) & (K Units)
    Table 56. World Split Influenza Vaccine Production by Application (2024-2029) & (K Units)
    Table 57. World Split Influenza Vaccine Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Split Influenza Vaccine Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Split Influenza Vaccine Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Split Influenza Vaccine Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
    Table 62. Sanofi Pasteur Major Business
    Table 63. Sanofi Pasteur Split Influenza Vaccine Product and Services
    Table 64. Sanofi Pasteur Split Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Sanofi Pasteur Recent Developments/Updates
    Table 66. Sanofi Pasteur Competitive Strengths & Weaknesses
    Table 67. CSL Seqirus Basic Information, Manufacturing Base and Competitors
    Table 68. CSL Seqirus Major Business
    Table 69. CSL Seqirus Split Influenza Vaccine Product and Services
    Table 70. CSL Seqirus Split Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. CSL Seqirus Recent Developments/Updates
    Table 72. CSL Seqirus Competitive Strengths & Weaknesses
    Table 73. GSK Basic Information, Manufacturing Base and Competitors
    Table 74. GSK Major Business
    Table 75. GSK Split Influenza Vaccine Product and Services
    Table 76. GSK Split Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. GSK Recent Developments/Updates
    Table 78. GSK Competitive Strengths & Weaknesses
    Table 79. Seqirus, Inc. Basic Information, Manufacturing Base and Competitors
    Table 80. Seqirus, Inc. Major Business
    Table 81. Seqirus, Inc. Split Influenza Vaccine Product and Services
    Table 82. Seqirus, Inc. Split Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Seqirus, Inc. Recent Developments/Updates
    Table 84. Seqirus, Inc. Competitive Strengths & Weaknesses
    Table 85. straZeneca Basic Information, Manufacturing Base and Competitors
    Table 86. straZeneca Major Business
    Table 87. straZeneca Split Influenza Vaccine Product and Services
    Table 88. straZeneca Split Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. straZeneca Recent Developments/Updates
    Table 90. Dalian Yali Peak Basic Information, Manufacturing Base and Competitors
    Table 91. Dalian Yali Peak Major Business
    Table 92. Dalian Yali Peak Split Influenza Vaccine Product and Services
    Table 93. Dalian Yali Peak Split Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 94. Global Key Players of Split Influenza Vaccine Upstream (Raw Materials)
    Table 95. Split Influenza Vaccine Typical Customers
    Table 96. Split Influenza Vaccine Typical Distributors
List of Figure
    Figure 1. Split Influenza Vaccine Picture
    Figure 2. World Split Influenza Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Split Influenza Vaccine Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Split Influenza Vaccine Production (2018-2029) & (K Units)
    Figure 5. World Split Influenza Vaccine Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Split Influenza Vaccine Production Value Market Share by Region (2018-2029)
    Figure 7. World Split Influenza Vaccine Production Market Share by Region (2018-2029)
    Figure 8. North America Split Influenza Vaccine Production (2018-2029) & (K Units)
    Figure 9. Europe Split Influenza Vaccine Production (2018-2029) & (K Units)
    Figure 10. China Split Influenza Vaccine Production (2018-2029) & (K Units)
    Figure 11. Japan Split Influenza Vaccine Production (2018-2029) & (K Units)
    Figure 12. Split Influenza Vaccine Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Split Influenza Vaccine Consumption (2018-2029) & (K Units)
    Figure 15. World Split Influenza Vaccine Consumption Market Share by Region (2018-2029)
    Figure 16. United States Split Influenza Vaccine Consumption (2018-2029) & (K Units)
    Figure 17. China Split Influenza Vaccine Consumption (2018-2029) & (K Units)
    Figure 18. Europe Split Influenza Vaccine Consumption (2018-2029) & (K Units)
    Figure 19. Japan Split Influenza Vaccine Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Split Influenza Vaccine Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Split Influenza Vaccine Consumption (2018-2029) & (K Units)
    Figure 22. India Split Influenza Vaccine Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Split Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Split Influenza Vaccine Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Split Influenza Vaccine Markets in 2022
    Figure 26. United States VS China: Split Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Split Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Split Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Split Influenza Vaccine Production Market Share 2022
    Figure 30. China Based Manufacturers Split Influenza Vaccine Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Split Influenza Vaccine Production Market Share 2022
    Figure 32. World Split Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Split Influenza Vaccine Production Value Market Share by Type in 2022
    Figure 34. Aldult
    Figure 35. Child
    Figure 36. World Split Influenza Vaccine Production Market Share by Type (2018-2029)
    Figure 37. World Split Influenza Vaccine Production Value Market Share by Type (2018-2029)
    Figure 38. World Split Influenza Vaccine Average Price by Type (2018-2029) & (US$/Unit)
    Figure 39. World Split Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Split Influenza Vaccine Production Value Market Share by Application in 2022
    Figure 41. Hospital
    Figure 42. Clinic
    Figure 43. World Split Influenza Vaccine Production Market Share by Application (2018-2029)
    Figure 44. World Split Influenza Vaccine Production Value Market Share by Application (2018-2029)
    Figure 45. World Split Influenza Vaccine Average Price by Application (2018-2029) & (US$/Unit)
    Figure 46. Split Influenza Vaccine Industry Chain
    Figure 47. Split Influenza Vaccine Procurement Model
    Figure 48. Split Influenza Vaccine Sales Model
    Figure 49. Split Influenza Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 50. Methodology
    Figure 51. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sanofi Pasteur
CSL Seqirus
GSK
Seqirus, Inc.
straZeneca
Dalian Yali Peak

Related Reports

Global Split Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Split Influenza Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 28 Apr 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Split Influenza Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Split Influenza Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Split Influenza Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 21 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Split Influenza Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Split Influenza Vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>